Delivery of antiviral small interfering RNA with gold nanoparticles inhibits dengue virus infection in vitro

Journal of General Virology

Volumn 95, Issue PART 8, 2014, Pages 1712-1722

  Paul, Amber M ^a   Shi, Yongliang ^a   Acharya, Dhiraj ^a   Douglas, Jessica R ^a   Cooley, Amanda ^a   Anderson, John F ^b   Huang, Faqing ^a   Bai, Fengwei ^a  

^a The University of Southern Mississippi   (United States)

^b Department of Chemistry and Biochemistry University of Southern Mississippi ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; GOLD NANOPARTICLE; NUCLEASE; RIBONUCLEASE; SMALL INTERFERING RNA;

ANIMAL CELL; ANTIBODY DEPENDENT ENHANCEMENT; ARTICLE; BIOCOMPATIBILITY; BIODEGRADATION; CONTROLLED STUDY; DENGUE; DENGUE VIRUS 1; DENGUE VIRUS 2; DENGUE VIRUS 3; DENGUE VIRUS 4; ENZYMATIC DEGRADATION; IN VITRO STUDY; IN VIVO STUDY; INFECTION CONTROL; NONHUMAN; PRIORITY JOURNAL; RNA SEQUENCE; RNA STABILITY; SEROTYPE; STATIC ELECTRICITY; SURFACE CHARGE; URINARY EXCRETION; VERO CELL LINE; VIRAL GENE DELIVERY SYSTEM; VIRION; VIRUS REPLICATION; ZETA POTENTIAL;

ANIMALS; ANTIVIRAL AGENTS; CERCOPITHECUS AETHIOPS; DENGUE VIRUS; DRUG CARRIERS; GOLD; NANOPARTICLES; RNA, SMALL INTERFERING; VERO CELLS; VIRUS RELEASE; VIRUS REPLICATION;

EID: 84904437500     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.066084-0     Document Type: Article

References (61)

1. Alhoot, M. A., Wang, S. M. & Sekaran, S. D. (2011). Inhibition of dengue virus entry and multiplication into monocytes using RNA interference. PLoS Negl Trop Dis 5, e1410.
2. Bai, F., Wang, T., Pal, U., Bao, F., Gould, L. H. & Fikrig, E. (2005). Use of RNA interference to prevent lethal murine west nile virus infection. J Infect Dis 191, 1148-1154.
3. Bai, Z., Liu, L., Tu, Z., Yao, L., Liu, J., Xu, B., Tang, B., Liu, J., Wan, Y. & other authors (2008). Real-time PCR for detecting circulating dengue virus in the Guangdong Province of China in 2006. J Med Microbiol 57, 1547-1552.
4. Bhatt, S., Gething, P. W., Brady, O. J., Messina, J. P., Farlow, A. W., Moyes, C. L., Drake, J. M., Brownstein, J. S., Hoen, A. G. & other authors (2013). The global distribution and burden of dengue. Nature 496, 504-507.
5. Bonafé, N., Rininger, J. A., Chubet, R. G., Foellmer, H. G., Fader, S., Anderson, J. F., Bushmich, S. L., Anthony, K., Ledizet, M. & other authors (2009). A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+cells. Vaccine 27, 213-222.
6. Boussif, O., Lezoualc'h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B. & Behr, J. P. (1995). A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A 92, 7297-7301.
7. Breunig, M., Lungwitz, U., Liebl, R. & Goepferich, A. (2007). Breaking up the correlation between efficacy and toxicity for nonviral gene delivery. Proc Natl Acad Sci U S A 104, 14454-14459.
8. Chithrani, B. D. & Chan, W. C. (2007). Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett 7, 1542-1550.
9. Conde, J., Ambrosone, A., Sanz, V., Hernandez, Y., Marchesano, V., Tian, F., Child, H., Berry, C. C., Ibarra, M. R. & other authors (2012). Design of multifunctional gold nanoparticles for in vitro and in vivo gene silencing. ACS Nano 6, 8316-8324.
10. Conde, J., Tian, F., Hernández, Y., Bao, C., Cui, D., Janssen, K. P., Ibarra, M. R., Baptista, P. V., Stoeger, T. & de la Fuente, J. M. (2013). In vivo tumor targeting via nanoparticle-mediated therapeutic siRNA coupled to inflammatory response in lung cancer mouse models. Biomaterials 34, 7744-7753.
11. Connor, E. E., Mwamuka, J., Gole, A., Murphy, C. J. & Wyatt, M. D. (2005). Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 1, 325-327.
12. Dalrymple, N. & Mackow, E. R. (2011). Productive dengue virus infection of human endothelial cells is directed by heparan sulfatecontaining proteoglycan receptors. J Virol 85, 9478-9485.
13. de Fougerolles, A. R. (2008). Delivery vehicles for small interfering RNA in vivo. Hum Gene Ther 19, 125-132.
14. de Jong, W. H. & Borm, P. J. (2008). Drug delivery and nanoparticles: applications and hazards. Int J Nanomedicine 3, 133-149.
15. Elbakry, A., Zaky, A., Liebl, R., Rachel, R., Goepferich, A. & Breunig, M. (2009). Layer-by-layer assembled gold nanoparticles for siRNA delivery. Nano Lett 9, 2059-2064.
16. Gao, K. & Huang, L. (2009). Nonviral methods for siRNA delivery. Mol Pharm 6, 651-658.
17. Gerber, A., Bundschuh, M., Klingelhofer, D. & Groneberg, D. A. (2013). Gold nanoparticles: recent aspects for human toxicology. J Occup Med Toxicol 8, 32.
18. Gilleron, J., Querbes, W., Zeigerer, A., Borodovsky, A., Marsico, G., Schubert, U., Manygoats, K., Seifert, S., Andree, C. & other authors (2013). Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape. Nat Biotechnol 31, 638-646.
19. Goel, R., Swanlund, D., Coad, J., Paciotti, G. F. & Bischof, J. C. (2007). TNF-alpha-based accentuation in cryoinjury-dose, delivery, and response. Mol Cancer Ther 6, 2039-2047.
20. Goel, R., Shah, N., Visaria, R., Paciotti, G. F. & Bischof, J. C. (2009). Biodistribution of TNF-alpha-coated gold nanoparticles in an in vivo model system. Nanomedicine (Lond) 4, 401-410.
21. Goodman, C. M., McCusker, C. D., Yilmaz, T. & Rotello, V. M. (2004). Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjug Chem 15, 897-900.
22. Gubler, D. J. (2002). The global emergence/resurgence of arboviral diseases as public health problems. Arch Med Res 33, 330-342.
23. Halstead, S. B. (1982). Immune enhancement of viral infection. Prog Allergy 31, 301-364.
24. Halstead, S. B. (2007). Dengue. Lancet 370, 1644-1652.
25. Huang, F. & Shi, Y. (2010). Synthesis of symmetrical thiol-adenosine conjugate and 5 thiol-RNA preparation by efficient one-step transcription. Bioorg Med Chem Lett 20, 6254-6257.
26. Idrees, S. & Ashfaq, U. A. (2013). RNAi: antiviral therapy against dengue virus. Asian Pac J Trop Biomed 3, 232-236.
27. Kliks, S. C., Nisalak, A., Brandt, W. E., Wahl, L. & Burke, D. S. (1989). Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg 40, 444-451.
28. Lee, M. Y., Park, S. J., Park, K., Kim, K. S., Lee, H. & Hahn, S. K. (2011). Target-specific gene silencing of layer-by-layer assembled gold-cysteamine/siRNA/PEI/HA nanocomplex. ACS Nano 5, 6138-6147.
29. Lewinski, N., Colvin, V. & Drezek, R. (2008). Cytotoxicity of nanoparticles. Small 4, 26-49.
30. Libutti, S. K., Paciotti, G. F., Byrnes, A. A., Alexander, H. R., Jr, Gannon, W. E., Walker, M., Seidel, G. D., Yuldasheva, N. & Tamarkin, L. (2010). Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine. Clin Cancer Res 16, 6139-6149.
31. Mitra, M., Kandalam, M., Rangasamy, J., Shankar, B., Maheswari, U. K., Swaminathan, S. & Krishnakumar, S. (2013). Novel epithelial cell adhesion molecule antibody conjugated polyethyleneiminecapped gold nanoparticles for enhanced and targeted small interfering RNA delivery to retinoblastoma cells. Mol Vis 19, 1029-1038.
32. Mota, J. & Rico-Hesse, R. (2009). Humanized mice show clinical signs of dengue fever according to infecting virus genotype. J Virol 83, 8638-8645.
33. Pham, A. M., Langlois, R. A. & TenOever, B. R. (2012). Replication in cells of hematopoietic origin is necessary for Dengue virus dissemination. PLoS Pathog 8, e1002465.
34. Puccioni-Sohler, M., Orsini, M. & Soares, C. N. (2012). Dengue: a new challenge for neurology. Neurol Int 4, e15.
35. Ramos, M. M., Mohammed, H., Zielinski-Gutierrez, E., Hayden, M. H., Lopez, J. L., Fournier, M., Trujillo, A. R., Burton, R., Brunkard, J. M. & other authors (2008). Epidemic dengue and dengue hemorrhagic fever at the Texas-Mexico border: results of a household-based seroepidemiologic survey, December 2005. Am J Trop Med Hyg 78, 364-369.
36. Reynolds, J. L., Law, W. C., Mahajan, S. D., Aalinkeel, R., Nair, B., Sykes, D. E., Yong, K. T., Hui, R., Prasad, P. N. & Schwartz, S. A. (2012). Nanoparticle based galectin-1 gene silencing, implications in methamphetamine regulation of HIV-1 infection in monocyte derived macrophages. J Neuroimmune Pharmacol 7, 673-685.
37. Richards Grayson, A. C., Doody, A. M. & Putnam, D. (2006). Biophysical and structural characterization of polyethyleniminemediated siRNA delivery in vitro. Pharm Res 23, 1868-1876.
38. Sadon, N., Delers, A., Jarman, R. G., Klungthong, C., Nisalak, A., Gibbons, R. V. & Vassilev, V. (2008). A new quantitative RT-PCR method for sensitive detection of dengue virus in serum samples. J Virol Methods 153, 1-6.
39. Shukla, R., Bansal, V., Chaudhary, M., Basu, A., Bhonde, R. R. & Sastry, M. (2005). Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. Langmuir 21, 10644-10654.
40. Song, W. J., Du, J. Z., Sun, T. M., Zhang, P. Z. & Wang, J. (2010). Gold nanoparticles capped with polyethyleneimine for enhanced siRNA delivery. Small 6, 239-246.
41. Spurr, A. R. (1969). A low-viscosity epoxy resin embedding medium for electron microscopy. J Ultrastruct Res 26, 31-43.
42. Stein, D. A., Perry, S. T., Buck, M. D., Oehmen, C. S., Fischer, M. A., Poore, E., Smith, J. L., Lancaster, A. M., Hirsch, A. J. & other authors (2011). Inhibition of dengue virus infections in cell cultures and in AG129 mice by a small interfering RNA targeting a highly conserved sequence. J Virol 85, 10154-10166.
43. Storhoff, J. J., Elghanian, R., Mucic, R. C., Mirkin, C. A. & Letsinger, R. L. (1998). One-pot colorimetric differentiation of polynucleotides with single base imperfections using gold nanoparticles probes. J Am Chem Soc 120, 1959-1964.
44. Subramanya, S., Kim, S. S., Abraham, S., Yao, J., Kumar, M., Kumar, P., Haridas, V., Lee, S. K., Shultz, L. D. & other authors (2010). Targeted delivery of small interfering RNA to human dendritic cells to suppress dengue virus infection and associated proinflammatory cytokine production. J Virol 84, 2490-2501.
45. Thomas, M. & Klibanov, A. M. (2003). Conjugation to gold nanoparticles enhances polyethylenimine's transfer of plasmid DNA into mammalian cells. Proc Natl Acad Sci U S A 100, 9138-9143.
46. Tomashek, K. M. & Margolis, H. S. (2011). Dengue: a potential transfusion-transmitted disease. Transfusion 51, 1654-1660.
47. Torchilin, V. P. (2005). Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 4, 145-160.
48. Urban-Klein, B., Werth, S., Abuharbeid, S., Czubayko, F. & Aigner, A. (2005). RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene Ther 12, 461-466.\
49. van der Schaar, H. M., Rust, M. J., Chen, C., van der Ende-Metselaar, H., Wilschut, J., Zhuang, X. & Smit, J. M. (2008). Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells. PLoS Pathog 4, e1000244.
50. Wang, X., Yu, B., Ren, W., Mo, X., Zhou, C., He, H., Jia, H., Wang, L., Jacob, S. T. & other authors (2013). Enhanced hepatic delivery of siRNA and microRNA using oleic acid based lipid nanoparticle formulations. J Control Release 172, 690-698.
51. Wilder-Smith, A., Ooi, E. E., Vasudevan, S. G. & Gubler, D. J. (2010). Update on dengue: epidemiology, virus evolution, antiviral drugs, and vaccine development. Curr Infect Dis Rep 12, 157-164.
52. Wu, S. J., Grouard-Vogel, G., Sun, W., Mascola, J. R., Brachtel, E., Putvatana, R., Louder, M. K., Filgueira, L., Marovich, M. A. & other authors (2000). Human skin Langerhans cells are targets of dengue virus infection. Nat Med 6, 816-820.
53. Xi, Z., Ramirez, J. L. & Dimopoulos, G. (2008). The Aedes aegypti Toll pathway controls dengue virus infection. PLoS Pathog 4, e1000098.
54. Yang, C., Yang, H., Wu, J., Meng, Z., Xing, R., Tian, A., Tian, X., Guo, L., Zhang, Y. & other authors (2013). No overt structural or functional changes associated with PEG-coated gold nanoparticles accumulation with acute exposure in the mouse heart. Toxicol Lett 222, 197-203.
55. Ye, C., Abraham, S., Wu, H., Shankar, P. & Manjunath, N. (2011). Silencing early viral replication in macrophages and dendritic cells effectively suppresses flavivirus encephalitis. PLoS ONE 6, e17889.
56. Zhang, X. D., Wu, D., Shen, X., Liu, P. X., Yang, N., Zhao, B., Zhang, H., Sun, Y. M., Zhang, L. A. & Fan, F. Y. (2011). Size-dependent in vivo toxicity of PEG-coated gold nanoparticles. Int J Nanomedicine 6, 2071-2081.
57. Zheng, D., Giljohann, D. A., Chen, D. L., Massich, M. D., Wang, X. Q., Iordanov, H., Mirkin, C. A. & Paller, A. S. (2012). Topical delivery of siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation. Proc Natl Acad Sci U S A 109, 11975-11980.
58. Zhong, Y. Q., Wei, J., Fu, Y. R., Shao, J., Liang, Y. W., Lin, Y. H., Liu, J. & Zhu, Z. H. (2008). [Toxicity of cationic liposome Lipofectamine 2000 in human pancreatic cancer Capan-2 cells]. Nan Fang Yi Ke Da Xue Xue Bao 28, 1981-1984 (in Chinese).
59. Zhou, J., Shum, K. T., Burnett, J. C. & Rossi, J. J. (2013). Nanoparticlebased delivery of RNAi therapeutics: progress and challenges. Pharmaceuticals 6, 85-107.
60. Zintchenko, A., Philipp, A., Dehshahri, A. & Wagner, E. (2008). Simple modifications of branched PEI lead to highly efficient siRNA carriers with low toxicity. Bioconjug Chem 19, 1448-1455.
61. Zuhorn, I. S., Kalicharan, R. & Hoekstra, D. (2002). Lipoplexmediated transfection of mammalian cells occurs through the cholesterol-dependent clathrin-mediated pathway of endocytosis. J Biol Chem 277, 18021-18028.